SMTL ID : 1u7t.1

Crystal Structure of ABAD/HSD10 with a Bound Inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-tetramer

Ligands

3 x TDT: 1-AZEPAN-1-YL-2-PHENYL-2-(4-THIOXO-1,4-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-5-YL)ETHANONE ADDUCT(Non-covalent)

TDT.1: 36 residues within 4Å: Chain A: G.17, S.20, G.21, L.22, D.41, L.42, S.45, A.63, D.64, V.65, C.91, A.92, G.93, A.95, V.96, A.97, V.120, T.153, A.154, S.155, Q.162, V.163, Q.165, Y.168, K.172, P.198, G.199, L.200, F.201, T.203, P.204, L.205, L.206, L.209, V.213, L.217 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:A.95, A:A.97, A:Q.162, A:P.198, A:L.206, A:V.213 Hydrogen bonds: A:G.17, A:L.22, A:L.42, A:D.64, A:V.65, A:A.92, A:G.93, A:Q.165, A:Y.168, A:K.172, A:F.201, A:F.201, A:T.203, A:L.205 Water bridges: A:G.23 TDT.3: 34 residues within 4Å: Chain C: G.17, S.20, G.21, L.22, D.41, L.42, A.63, D.64, V.65, C.91, A.92, G.93, A.95, V.96, A.97, V.120, T.153, A.154, S.155, Q.162, V.163, Q.165, Y.168, K.172, P.198, G.199, L.200, F.201, T.203, P.204, L.205, L.206, L.209, L.217 21 PLIP interactions: 21 interactions with chain C Hydrophobic interactions: C:A.95, C:Q.162, C:Q.165, C:P.198, C:L.206, C:L.209 Hydrogen bonds: C:S.20, C:L.22, C:L.42, C:D.64, C:V.65, C:A.92, C:G.93, C:Q.165, C:Y.168, C:K.172, C:F.201, C:F.201, C:T.203, C:L.205 Water bridges: C:G.23 TDT.4: 35 residues within 4Å: Chain D: G.17, S.20, G.21, L.22, D.41, L.42, A.63, D.64, V.65, C.91, A.92, G.93, A.95, V.96, A.97, V.120, T.153, A.154, S.155, Q.162, V.163, Q.165, Y.168, K.172, P.198, G.199, L.200, F.201, T.203, P.204, L.205, L.206, S.208, L.209, L.217 24 PLIP interactions: 24 interactions with chain D Hydrophobic interactions: D:A.95, D:A.97, D:Q.162, D:Q.165, D:P.198, D:L.209, D:L.217 Hydrogen bonds: D:L.22, D:L.42, D:D.64, D:D.64, D:V.65, D:C.91, D:G.93, D:Q.165, D:Y.168, D:K.172, D:F.201, D:F.201, D:T.203, D:T.203, D:L.205 Water bridges: D:S.20, D:G.23

1 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.2: 26 residues within 4Å: Chain B: G.17, A.19, S.20, G.21, L.22, D.41, L.42, A.63, D.64, V.65, C.91, A.92, G.93, V.120, T.153, A.154, S.155, Y.168, K.172, P.198, G.199, L.200, F.201, T.203, P.204, L.206 16 PLIP interactions: 16 interactions with chain B Hydrophobic interactions: B:P.198 Hydrogen bonds: B:G.17, B:S.20, B:S.20, B:L.22, B:L.42, B:D.64, B:D.64, B:V.65, B:A.92, B:G.93, B:Y.168, B:K.172, B:F.201, B:F.201 Water bridges: B:G.23

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kissinger, C.R. et al., Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. J.Mol.Biol. (2004)

Release Date

2004-10-05

Peptides

3-hydroxyacyl-CoA dehydrogenase type II: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

3-hydroxyacyl-CoA dehydrogenase type II